创新药龙头再获天价大单,一季度净利约去年全年2倍

21世纪经济报道
Apr 13

炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!   记者丨李益文    编辑丨叶映橙   4月12日晚间,海思科(002653.SZ)连发三份重磅公告,交出了一份极具“反转色彩”的成绩单。公告显示,公司在经历2025年利润短暂承压后,2026年一季度业绩实现爆发式增长,同时宣布与全球生物制药巨头艾伯维(AbbVie)达成总额超7亿美元的授权合作。   据海思科2026年...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10